Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

13.50
Delayed Data
As of Dec 09
 -0.65 / -4.59%
Today’s Change
3.88
Today|||52-Week Range
14.60
+113.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues0.000.00236.9K299.4K
 
 
 
Depreciation And Amortization38.8K39.1K39.2K952.00
 
 
 
 
 
 
Operating ExpensesGross Income-38.8K-39.1K----
 
 
 
General Expenses10.5M9.4M9.7M10.4M
 
 
 
 
 
Research And Development7.9M6.5M6.9M7.2M
 
 
 
 
 
Total Operating Expenses10.5M9.4M9.7M10.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.5M-9.4M-9.5M-10.1M
 
 
 
 
 
Other Expenses205.7K205.7K10.4K1.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-9.0M-9.3M-9.9M
 
 
 
 
 
Income Taxes0.000.00-26.8K-8.8K
 
 
 
Net Income-10.2M-9.0M-9.3M-9.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.6M17.7M17.8M17.8M
 
 
 
 
 
Shares To Calculate EPS Diluted17.6M17.7M17.8M17.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.58-$0.51-$0.52-$0.56
 
 
 
 
 
EPS Diluted-$0.58-$0.51-$0.52-$0.56